Skip to main content

Table 1 Demographic characteristics of MDR-TB cases in Guizhou Province, 2014–2020 (n, %)

From: Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020

Variables

2014

2015

2016

2017

2018

2019

2020

Total

Total

145

165

186

225

240

269

436

1666

Percentage change (%)

13.8

12.7

21.0

6.7

12.1

62.1

Gender

        

Male

101 (69.7)

125 (75.8)

130 (69.9)

142 (63.1)

173 (72.1)

177 (65.8)

311 (71.3)

1159 (69.6)

Female

44 (30.3)

40 (24.2)

56 (30.1)

83 (36.9)

67 (27.9)

92 (34.2)

125 (28.7)

507 (30.4)

Sex ratio

2.3

3.1

2.3

1.7

2.6

1.9

2.5

2.3

Age

        

< 25

24 (16.6)

28 (17.0)

35 (18.8)

50 (22.2)

43 (17.9)

32 (11.9)

68 (15.6)

280 (16.8)

25–65

114 (78.6)

125 (75.8)

141 (75.8)

159 (70.7)

168 (70.0)

213 (79.2)

303 (69.5)

1223 (73.4)

 ≥ 65

7 (4.8)

12 (7.3)

10 (5.4)

16 (7.1)

29 (12.1)

24 (8.9)

65 (14.9)

163 (9.8)

Ethnic group

        

Han

127 (87.6)

141 (85.5)

167 (89.8)

200 (88.9)

185 (77.1)

212 (78.8)

342 (78.4)

1374 (82.5)

Others

18 (12.4)

24 (14.5)

19 (10.2)

25 (11.1)

55 (22.9)

57 (21.2)

94 (21.6)

292 (17.5)

Occupation

        

Student

6 (4.1)

1 (0.6)

1 (0.5)

10 (4.4)

15 (6.3)

4 (1.5)

20 (4.6)

57 (3.4)

Government worker

16 (11.0)

4 (2.4)

4 (2.2)

2 (0.9)

15 (6.3)

15 (5.6)

12 (2.8)

68 (4.1)

Farmer

68 (46.9)

92 (55.8)

111 (59.7)

104 (46.2)

104 (43.3)

86 (32.0)

161 (36.9)

726 (43.6)

Migrant worker

13 (9.0)

8 (4.8)

13 (7.0)

51 (22.7)

72 (30.0)

154 (57.2)

229 (52.5)

540 (32.4)

Others (unemployed)

42 (29.0)

60 (36.4)

57 (30.6)

58 (25.8)

34 (14.2)

10 (3.7)

14 (3.2)

275 (16.5)

Anti-TB drug history

        

Never use

0 (0.0)

0 (0.0)

0 (0.0)

16 (7.1)

21 (8.8)

15 (5.6)

28 (6.4)

80 (4.8)

Only 1st-line drugs

114 (78.6)

162 (98.2)

174 (93.5)

193 (85.8)

187 (77.9)

235 (87.4)

397 (91.1)

1462 (87.8)

1st- and 2nd-line drugs

31 (21.4)

3 (1.8)

12 (6.5)

16 (7.1)

32 (13.3)

19 (7.1)

11 (2.5)

124 (7.4)

  1. MDR-TB multidrug-resistant tuberculosis, anti-TB anti-tuberculosis